🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

This #InvisibleDisabilitiesWeek, we’re recognizing and raising awareness for people with conditions that aren’t always apparent, like many of those living with #TGCT. Learn more about this disease here: tgcttruth.com

This #VeteransDay, Deciphera honors the bravery of our U.S. Veterans. This year, our employee-led Culture group donated over 100 lbs. of Halloween candy to #TreatsForTroops to provide extra comfort to the Veteran community in a unique and fun way. Thank you to all who serve.

This #Thanksgiving, we're grateful for the opportunity to improve the lives of people living with cancer and make a difference in the communities where we live and work. We’re especially thankful to our Deciphera team for their unwavering dedication. Happy Thanksgiving!

Happy holidays from our Deciphera team! As we reflect on an exciting 2024, we’re grateful to be part of this fantastic team and looking forward to another great year. See you in 2025! #TheDecipheraDifference

This weekend, Margarida Duarte, Deciphera’s Global Chief Commercial Officer, will participate on the “Europe Matters: Creating Value for US Biotechs” panel hosted by INSEAD at #JPM25. Check it out!

Please join us in welcoming Ryota Udagawa, Deciphera’s new President and Chief Executive Officer. Ryota has been a part of the Ono Pharma team since 2002, and joined as Deciphera’s CEO at the end of 2024. Welcome, Ryota!

Today, Ono Pharma, the parent company of Deciphera, announced financial results for the third quarter of fiscal year 2024. Read more: ono-pharma.com/en/ir/library/…

Today is #WorldCancerDay, organized by @UICC to raise awareness about #cancer and encourage its prevention. At Deciphera, we're working to discover and develop important new medicines to improve the lives of people living with cancer. #UnitedByUnique

On this International Day of Women and Girls in Science, we express our gratitude for the incredible and dedicated work the women at Deciphera do to defeat #cancer and make a difference for the patient groups and communities in which we live and work. #IDWGS #WomenInScience

We are proud to announce the U.S. FDA approval of a new medicine for people living with tenosynovial giant cell tumor (#TGCT). Read more in today’s press release: bit.ly/3PZlmwY Learn more: bit.ly/4b8uDwn

We are excited about the recent U.S. FDA approval of a new medicine for people living with tenosynovial giant cell tumor (#TGCT). Read more: bit.ly/3PZlmwY Learn more: bit.ly/4b8uDwn

Today, on #RareDiseaseDay, we’re highlighting tenosynovial giant cell tumor (#TGCT), a rare, locally aggressive neoplasm that can negatively impact quality of life for those affected. Learn more: tgcttruth.com/about-tgct @RareDiseaseDay

Last week, Deciphera’s Management team had an incredible trip to Japan, visiting our parent company Ono Pharma at its headquarters in Osaka. Thank you to our hosts for the collaborative and productive week. We enjoyed our time together!

We want to recognize the Deciphera team, some of whom pictured here with our CEO, Ryota Udagawa. They were instrumental in the recent U.S. FDA approval of a new medicine for those living with tenosynovial giant cell tumor (#TGCT). Thanks, team! Learn more: bit.ly/4b8uDwn

April 7th marks the founding of the World Health Organization (WHO) as well as #WorldHealthDay. We're proud to support this initiative drawing attention to health topics impacting those all over the world and remain steadfast in our commitment to bring transformational medicines to patients in need. Learn

We’re in Padova, Italy for EMSOS 2025, the European Musculo-Skeletal Oncology Society annual meeting! Our team will be sharing an oral presentation and two e-posters on Vimseltinib. Learn more about this conference: bit.ly/42OvVch #TGCT #EMSOS2025

Today, 小野薬品工業株式会社, the parent company of Deciphera, announced its financial results for the fourth quarter and fiscal year 2024. Read more: bit.ly/42O4uAx

Today, we shine a light on those who have served in the armed forces. Thank you for your courage and commitment. Your dedication inspires us every day. #MemorialDay

We joined 小野薬品工業株式会社 at #ASCO25 this week to support their presentations on tirabrutinib and ONO-4578. We were thrilled to join this event and to connect with thought leaders in #oncology from around the globe. #CancerResearch

Today marks the 1-year anniversary of Deciphera’s acquisition by 小野薬品工業株式会社! Together, we’ve expanded our global footprint, strengthened our pipeline, and deepened our collective impact across our therapeutic areas. As we reflect on all we’ve accomplished together, we are